Barbara W. Bodem
Insider
First SEC filing: April 8, 2022 · Latest: June 4, 2026
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 2, 2026 | BMRN | A | 7,490 | · | · | 21,045 Direct | +55.26% | Acquired | (price as of 2026-10-05) |
| May 20, 2026 | OPCH | A | 8,997 | · | · | 21,087 Direct | +74.42% | Acquired | (price as of 2026-10-06) |
| May 19, 2026 | ENOV | A | 9,346 | · | · | 24,201 Direct | +62.91% | Acquired | (price as of 2026-10-06) |
| May 21, 2025 | ENOV | A | 6,598 | · | · | 14,855 Direct | +79.91% | Acquired | (price as of 2026-10-06) |
| May 20, 2025 | BMRN | A | 6,650 | · | · | 13,555 Direct | +96.31% | Acquired | (price as of 2026-10-05) |
| May 14, 2025 | OPCH | A | 5,034 | · | · | 12,090 Direct | +71.34% | Acquired | (price as of 2026-10-06) |
| May 21, 2024 | BMRN | A | 4,720 | · | · | 6,900 Direct | +216.51% | Acquired | (price as of 2026-10-05) |
| May 20, 2024 | ENOV | A | 4,338 | · | · | 8,257 Direct | +110.69% | Acquired | (price as of 2026-10-06) |
| May 15, 2024 | OPCH | A | 5,325 | · | · | 7,056 Direct | +307.63% | Acquired | (price as of 2026-10-06) |
| April 1, 2024 | OPCH | A | 1,731 | · | · | 1,731 Direct | · | Acquired | (price as of 2026-10-06) |
| Dec. 27, 2023 | BMRN | A | 2,180 | · | · | 2,180 Direct | · | Acquired | (price as of 2026-10-05) |
| May 16, 2023 | ENOV | A | 4,167 | · | · | 4,167 Direct | · | Acquired | (price as of 2026-10-06) |
| May 16, 2023 | ENOV | A | 1,875 | · | · | 3,919 Direct | +91.73% | Acquired | (price as of 2026-10-06) |
| June 7, 2022 | ENOV | A | 3,464 | · | · | 3,464 Direct | · | Acquired | (price as of 2026-10-06) |
| June 7, 2022 | ENOV | A | 1,648 | · | · | 2,044 Direct | +416.16% | Acquired | (price as of 2026-10-06) |
| June 7, 2022 | ENOV | A | 396 | · | · | 396 Direct | · | Acquired | (price as of 2026-10-06) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| May 16, 2023 | ENOV | Director stock option (right to buy) | Common stock, par value $0.001 | $56.76 | May 16, 2030 | 4,167 | Acquired |
| June 7, 2022 | ENOV | Director Stock Option (right to buy) | Common stock, par value $.001 | $67.28 | June 7, 2029 | 3,464 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| April 8, 2022 | ENOV | No securities are beneficially owned | 0 | Direct |